News About: Pharm. Industry
Drug makers oppose new drug pricing reform
The Korea Pharmaceutical Manufacturers Association and the government have clashed over the latter’s plan to cut drug prices by an average of 17 percent starting next year.
On Thursday, the KPMA issued a statement,...
Drugmakers’ protest may face backlash
The Korea Pharmaceutical Manufacturers Association said Thursday that it will take every possible measure to prevent the government’s plan to senseless policy to cut drug price for the survival of the pharmaceutical i...
11 pharmaceutical firms own stakes in general programming cable television channels
A total of 11 leading pharmaceutical companies, including Ildong and Hanmi, made investments on five general programming cable broadcasters - Chosun Ilbo, JoongAng Ilbo, Dong-A Ilbo, Maeil Business Newspaper and Yonha...
No more homegrown drugs are available
The government’s plan to cut drug prices by an average of 17 percent starting next year has triggered vehement protests from the domestic pharmaceutical community.
Asserting that the government’s “senseless” plan w...
Faint hope mounting over new health minister
The domestic pharmaceutical industry has still pinned hopes on Health and Welfare Minister Rim Che-min.
Rim, 53, minister of the Prime Minister’s Office, is one of the most recognized economic bureaucrats under the...
National labor union seeking public hearing over drug price cuts
The Federation of Korean Chemical Workers’ Union (FKCU) said Friday that it will seek to hold a public hearing at the National Assembly as part of its plan to review the government’s “ill-conceived” plan to cut drug p...
Competition stiff for prescription drugs market
Multinational pharmaceutical firms are stepping up their marketing in domestic hypertension, hyperlipidemia, diabetes and hepatitis B markets, according to marketing sources.
In hypertension market, Novartis’s Diov...
Pharmaceutical companies stash cash as outlook stays gloomy
Publicly held drug firms in Korea are holding sizable amounts of cash – an indication that they are growing more pessimistic over the outlook for future growth, according to Yakup.com.
Yakup.com said that the cash ...
Conflict escalates over corporate restructuring
Labor unions and management of pharmaceutical firms are expected to clash over the layoff plans.
The Federation of Korean Chemical Workers’ Union said Friday that it will organize a consultative body consisting of ...
US NIH allocates additional funding to develop pyrimidinedione product as an anti-HIV drug
The US based ImQuest Pharmaceuticals Inc., a strategic partner of Samjin Pharmaceutical Co., has rectntly received an additional funding of $2.3 million from the National Institute of Allergy and Infectious Disease (N...
